Found: 1
Select item for more details and to access through your institution.
A multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxel in pancreatic adenocarcinoma.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 81, doi. 10.1007/s10637-021-01164-9
- By:
- Publication type:
- Article